Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02576652 · ClinicalTrials.gov registry record · Phase 4
Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement
A Phase 4 study, sponsored by Amgen.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT02576652 is a Phase 4 study that has completed, run by Amgen. The registered enrollment target is 6 participants.
The verdict
NCT02576652, a Phase 4 study, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the incidence of modeling-based bone formation in the femoral neck in participants who have received denosumab and are undergoing total hip replacement (THR).
Interventions
- PROCEDURE Total Hip Replacement
- OTHER Tetracycline
- OTHER Demeclocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-12-22 |
| Est. Completion | 2017-12-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02576652
The ClinicalTrials.gov registry entry for NCT02576652 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Total Hip Replacement is the first listed.
NCT02576652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02576652 about?
NCT02576652 is a clinical study titled "Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement". The primary objective of this study is to determine the incidence of modeling-based bone formation in the femoral neck in participants who have received denosumab and are undergoing total hip replacement (THR).
What is the current status of trial NCT02576652?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2015-12-22. Estimated completion is 2017-12-18.
What interventions are being tested in trial NCT02576652?
The interventions under investigation include: Total Hip Replacement (PROCEDURE), Tetracycline (OTHER), Demeclocycline (OTHER).
Who is sponsoring clinical trial NCT02576652?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.